Sequenom Newswire (Page 4)

Sequenom Newswire (Page 4)

Comprehensive Real-Time News Feed for Sequenom. (Page 4)

Results 61 - 79 of 79 in Sequenom

  1. Supreme Court Declines Sequenom ReviewRead the original story w/Photo

    Jul 6, 2016 | JD Supra

    Last week the United States Supreme Court denied Sequenom's petition to review the Federal Circuit's holding in Sequenom Inc. v. Ariosa Diagnostic Inc. , 788 F.3d 1371 that claims directed to detecting fetal DNA in maternal blood were invalid for failing to recite patent eligible subject matter.

    Comment?

  2. William Blair Reaffirms Market Perform Rating for Sequenom Inc.Read the original story w/Photo

    Jul 4, 2016 | Daily Political

    ... . Several large investors have recently bought and sold shares of SQNM. BlackRock Fund Advisors raised its stake in Sequenom by 1.4% in the first quarter. BlackRock Fund Advisors now owns 4,615,722 shares of the company's stock valued at $6,508,000 ...

    Comment?

  3. Sequenom Inc. (SQNM) Earns Market Perform Rating from William BlairRead the original story w/Photo

    Jul 2, 2016 | AmericanBankingNews.com

    's stock had its "market perform" rating reaffirmed by equities research analysts at William Blair in a report released on Wednesday. Shares of Sequenom traded down 1.50% during midday trading on Wednesday, hitting $0.90.

    Comment?

  4. Watch List for Biotechnology Equities a " Genocea Biosciences,...Read the original story

    Jul 1, 2016 | Freshnews

    ... equities: Genocea Biosciences Inc. (NASDAQ: GNCA), BioDelivery Sciences International Inc. (NASDAQ: BDSI), Sequenom Inc. (NASDAQ: SQNM), and INSYS Therapeutics Inc. (NASDAQ: INSY). Learn more about these stocks by accessing their free trade alerts ...

    Comment?

  5. Sequenom, Inc. (SQNM) Position Held by Spark Investment Management LLCRead the original story w/Photo

    Jul 1, 2016 | Daily Political

    Spark Investment Management LLC continued to hold its stake in Sequenom, Inc. during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 265,300 shares of the company's stock at the end of the first quarter.

    Comment?

  6. Sequenom, Inc. (SQNM) Earns Market Perform Rating from William BlairRead the original story w/Photo

    Jun 29, 2016 | AmericanBankingNews.com

    's stock had its "market perform" rating reaffirmed by investment analysts at William Blair in a research note issued to investors on Wednesday. In other Sequenom news, CFO Carolyn Beaver purchased 30,000 shares of the company's stock in a transaction on Friday, June 10th.

    Comment?

  7. Weekly CEO Sells HighlightsRead the original story w/Photo

    Jun 28, 2016 | GuruFocus.com

    Natera CEO Matthew Rabinowitz sold 732,831 shares at a price of $11.94 on June 19. Natera has a market cap of $581.250 million; its shares were traded around $11.34 with a P/S ratio of 2.16. Natera faces competition with other companies such as Illumina Inc. , Sequenom Inc. and Counsyl Inc. The company expects an increase of competition as new tests and technologies are introduced.

    Comment?

  8. Supreme Court Declines to Review Sequenom RulingRead the original story w/Photo

    Jun 28, 2016 | JD Supra

    The U.S. Supreme Court has denied certiorari in Sequenom, Inc. v. Ariosa Diagnostics, Inc .

    Comment?

  9. Supreme Court Denies Sequenom's Petition for CertiorariRead the original story w/Photo

    Jun 28, 2016 | JD Supra

    On June 27, 2016, the U.S. Supreme Court, without comment, denied Sequenom's petition for certiorari, leaving in place the Court's previous rulings prohibiting the patenting of laws of nature and natural phenomenon. Sequenom filed its writ of certiorari with the U.S. Supreme Court on March 21, 2016, asking the Court to provide clarification regarding the limits of 35 U.S.C. 101.

    Comment?

  10. Biotech Industry Shaken by Supreme Court RulingRead the original story

    Jun 28, 2016 | P&T Community

    The Supreme Court has left biotech entrepreneurs worrying that their inventions may not be worth very much, according to an article posted on the STAT website. The justices have shaken up the industry by declining to hear an appeal from Sequenom, Inc., a California-based company that markets a prenatal test based on screening fetal DNA.

    Comment?

  11. Supreme Court Denies Certiorari in Sequenom v. AriosaRead the original story w/Photo

    Jun 27, 2016 | JD Supra

    The Supreme Court issued an order this morning denying certiorari in Sequenom, Inc. v. Ariosa Diagnostics, Inc. Patent Docs will provide more analysis of the Court's denial of certiorari in a subsequent post.

    Comment?

  12. Will the Supreme Court Clarify Patent-Eligibility?Read the original story w/Photo

    Jun 27, 2016 | JD Supra

    The United States Supreme Court is set to render its decision on the grant or denial of Sequenom, Inc.'s petition for writ of certiorari that posed the issue: Whether a novel method is patent-eligible where: a researcher is the first to discover a natural phenomenon; that unique knowledge motivates him to apply a new combination of known techniques to that discovery; and he thereby achieves a previously impossible result without preempting other uses of the discovery? As reported by BNA's Life Science and Industry Report , the Supreme Court held its last conference on June 23rd before adjourning for the summer, and the Sequenom petition is one of the yet-to-be released decisions from the 2016 judicial season.

    Comment?

  13. The Supreme Court Of The United States Denies Sequenoma s Petition Requesting Review Of...Read the original story

    Jun 27, 2016 | Freshnews

    Sequenom, Inc. , a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced today that the Supreme Court of the United States denied its petition to review decisions by lower Federal courts that the claims of Sequenom's U.S. Patent No. 6,258,540 are not patent eligible under the patent eligibility criteria established by the Supreme Court's Mayo Collaborative Services v.

    Comment?

  14. The Supreme Court Of The United States Denies Sequenom's Petition...Read the original story

    Jun 26, 2016 | BioSpace

    /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced today that the Supreme Court of denied its petition to review ...

    Comment?

  15. Brokerages Set Sequenom, Inc. (NASDAQ:SQNM) Price Target at $1.70Read the original story w/Photo

    Jun 26, 2016 | Daily Political

    Shares of Sequenom, Inc. have been assigned an average rating of "Hold" from the six ratings firms that are presently covering the company. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company.

    Comment?

  16. Sequenom, Inc. (NASDAQ:SQNM) Given Consensus Recommendation of "Hold" by AnalystsRead the original story w/Photo

    Jun 24, 2016 | AmericanBankingNews.com

    Shares of Sequenom, Inc. have received a consensus rating of "Hold" from the six research firms that are covering the firm. One research analyst has rated the stock with a sell rating and five have given a hold rating to the company.

    Comment?

  17. Weekly CFO Buys HighlightsRead the original story w/Photo

    Jun 21, 2016 | GuruFocus.com

    According to GuruFocus Insider Data, the recent CFO buys were: Orion Energy Systems Inc. , Connecture Inc. and Sequenom Inc. . CFO William T. Hull bought 93,500 shares at a price of $1.28 on June 13. The price of the stock has decreased by 4.69%.

    Comment?

  18. Amicus Briefs in Support of Sequenom's Petition for Certiorari:...Read the original story w/Photo

    Jun 20, 2016 | JD Supra

    In March, following the Federal Circuit's denial of Sequenom's petition for rehearing en banc , Sequenom filed a petition for certiorari for Supreme Court review of the Federal Circuit's decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc .

    Comment?

  19. Amicus Briefs in Support of Sequenom's Petition for Certiorari: Eli Lilly and Company et al.Read the original story w/Photo

    Jun 17, 2016 | JD Supra

    In March, following the Federal Circuit's denial of Sequenom's petition for rehearing en banc , Sequenom filed a petition for certiorari for Supreme Court review of the Federal Circuit's decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc .

    Comment?